Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Yellow skin? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Yellow skin have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.0% of all adverse event reports for CABOZANTINIB S-MALATE.

17
Reports of Yellow skin with CABOZANTINIB S-MALATE
0.0%
of all CABOZANTINIB S-MALATE reports
2
Deaths
6
Hospitalizations

How Dangerous Is Yellow skin From CABOZANTINIB S-MALATE?

Of the 17 reports, 2 (11.8%) resulted in death, 6 (35.3%) required hospitalization.

Is Yellow skin Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Yellow skin?

SUNITINIB MALATE (457) OCTREOTIDE (91) RIBAVIRIN (77) ADALIMUMAB (75) DIMETHYL (71) ACETAMINOPHEN (60) IBUPROFEN (51) ATORVASTATIN (46) RUXOLITINIB (46) DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (45)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Yellow skin Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Yellow skin Reports All Drugs Causing Yellow skin CABOZANTINIB S-MALATE Demographics